Temporal Trends and Predictors for Cancer Clinical Trial Availability for Medically Underserved Populations

por Gerber, David E., Lakoduk, Ashley M., Priddy, Laurin L., Yan, Jingsheng, Xie, Xian-Jin
Publicado no Oncologist (2015)

Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer

por Gerber, David E., Boothman, David A., Fattah, Farjana J, Dong, Ying, Zhu, Hong, Skelton, Rachel A., Priddy, Laurin L., Vo, Peggy, Dowell, Jonathan E., Sarode, Venetia, Leff, Richard, Meek, Claudia, Xie, Yang, Schiller, Joan H.
Publicado no Lung Cancer (2015)